Association of HLA-DRB1*14 with rheumatic heart disease patients from Chandigarh, North India

References

• Anastasiou-Nana MI, Anderson JL, Carlquist JF, Nanas JN. (1986). HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: A search for immune response factors. Am Heart J 112:992–997.
   PubMed Web of Science ®Google Scholar
• Ayoub EM, Majeed HA. (2000). Poststreptococcal reactive arthritis. Curr Opin Rheumatol 12:306–310.
   PubMed Web of Science ®Google Scholar
• Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. (1986). Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 77:2019–2026.
   PubMed Web of Science ®Google Scholar
• Bowness P. (2002). HLA B27 in health and disease: A double-edged sword? Rheumatology (Oxford) 41:857–868.
   PubMed Web of Science ®Google Scholar
• Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. (2009). Some of the people, some of the time: Susceptibility to acute rheumatic fever. Circulation 119:742–753.
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Steer AC, Mulholland EK, Weber M. (2005). The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694.
   PubMed Web of Science ®Google Scholar
• Carlquist JF, Anderson JL. (1993). HLA, autoimmunity, and rheumatic heart disease. Apparent or real associations? Circulation 87:2060–2062.
   PubMed Web of Science ®Google Scholar
• Christiansen OB, Ring M, Rosgaard A, Grunnet N, Gluud C. (1999). Association between HLA-DR1 and -DR3 antigens and unexplained repeated miscarriage. Hum Reprod Update 5:249–255.
   PubMed Web of Science ®Google Scholar
• Deschamps I, Khalil I. (1993). The role of DQ α-β heterodimers in genetic susceptibility to insulin-dependent diabetes. Diabetes Metab Rev 9:71–92.
   PubMedGoogle Scholar
• DiSciascio G, Taranta A. (1980). Rheumatic fever in children. Am Heart J 99:635–658.
   PubMed Web of Science ®Google Scholar
• Erlich HA, Opelz G, Hansen J. (2001). HLA DNA typing and transplantation. Immunity 14:347–356.
   PubMed Web of Science ®Google Scholar
• Guédez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M. (1999). HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99:2784–2790.
   PubMed Web of Science ®Google Scholar
• Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. (1991). Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 83:1995–1998.
   PubMed Web of Science ®Google Scholar
• Gündogdu F, Islamoglu Y, Pirim I, Gurlertop Y, Dogan H, Arslan S, Sevimli S, Aksakal E, Senocak H. (2007). Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease. J Heart Valve Dis 16:293–299.
   PubMed Web of Science ®Google Scholar
• Hernández-Pacheco G, Aguilar-García J, Flores-Domínguez C, Rodríguez-Pérez JM, Pérez-Hernández N, Alvarez-Leon E, Reyes PA, Vargas-Alarcón G. (2003). MHC class II alleles in Mexican patients with rheumatic heart disease. Int J Cardiol 92:49–54.
   PubMed Web of Science ®Google Scholar
• Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatia ML. (1986). HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 27:172–178.
   PubMedGoogle Scholar
• Khosroshahi HE, Kahramanyol O, Doganci L. (1992). HLA and rheumatic fever in Turkish Children. Pediatr Cardiol 13:204–207.
   PubMed Web of Science ®Google Scholar
• Koyanagi T, Koga Y, Nishi H, Toshima H, Sasazuki T, Imaizumi T, Kimura A. (1996). DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J Mol Cell Cardiol 28:1349–1353.
   PubMed Web of Science ®Google Scholar
• Layrisse Z, Rodríguez-Iturbe B, García-Ramírez R, Rodríguez A, Tiwari J. (1983). Family studies of the HLA system in acute post-streptococcal glomerulonephritis. Hum Immunol 7:177–185.
   PubMed Web of Science ®Google Scholar
• Lee K, Park T, Park Y, Oh M, Kim Y. (1996). DNA polymorphism analysis of the HLA-DRB1 gene using polymerase chain reaction-sequence specific primer (PCR-SSP) among Korean subjects. J Biochem Mol Bio 29:45–51.
   Google Scholar
• Leech N, Sorrentino R, McCulloch DK, Nepom GT. (1995). Ultrastructural allelic variation in HLA-DQB1 promoter elements. Hum Immunol 43:251–258.
   PubMed Web of Science ®Google Scholar
• Maharaj B, Hammond MG, Appadoo B, Leary WP, Pudifin DJ. (1987). HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 76:259–261.
   PubMed Web of Science ®Google Scholar
• Maharaj B, Khedun SM, Hammond MG, van der Byl K. (1997). HLA-A, B, DR, and DQ antigens in Indian patients with severe chronic rheumatic heart disease. Jpn Heart J 38:663–668.
   PubMedGoogle Scholar
• Monplaisir N, Valette I, Bach JF. (1986). HLA antigens in 88 cases of rheumatic fever observed in Martinique. Tissue Antigens 28:209–213.
   PubMedGoogle Scholar
• Mytilineos J, Scherer S, Dunckley H, Chapman J, Middleton D, Opelz G. (1994). Comparison of serological and DNA HLA-DR typing results for transplantation in Western Europe, Eastern Europe, North America and South America. Transpl Int 7 Suppl 1:S519–S521.
   PubMedGoogle Scholar
• Nepom GT. (1995). Class II antigens and disease susceptibility. Annu Rev Med 46:17–25.
   PubMed Web of Science ®Google Scholar
• Olmez U, Turgay M, Ozenirler S, Tutkak H, Düzgün N, Duman M, Tokgöz G. (1993). Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Scand J Rheumatol 22:49–52.
   PubMed Web of Science ®Google Scholar
• Ozkan M, Carin M, Sönmez G, Senocak M, Ozdemir M, Yakut C. (1993). HLA antigens in Turkish race with rheumatic heart disease [see comment]. Circulation 87:1974–1978.
   PubMed Web of Science ®Google Scholar
• Pickles WN. (1943). Rheumatic fever. Lancet 2:241–244.
   Google Scholar
• Rajapakse CN, Halim K, Al-Orainey I, Al-Nozha M, Al-Aska AK. (1987). A genetic marker for rheumatic heart disease. Br Heart J 58:659–662.
   PubMedGoogle Scholar
• Read FEM, Ciocco A, Taussing HB. (1983). Frequency of rheumatic manifestations among siblings, parents, uncles, aunts and grandparents of rheumatic and control patients. Am J Hyg 27:719–737.
   Google Scholar
• Reddy KS, Narula J, Bhatia R, Shailendri K, Koicha M, Taneja V, Jhingan B, Pothineni RB, Malaviya AN, Mehra NK. (1990). Immunologic and immunogenetic studies in rheumatic fever and rheumatic heart disease. Indian J Pediatr 57:693–700.
   PubMedGoogle Scholar
• Rehman S, Akhtar N, Ahmad W, Ayub Q, Mehdi SQ, Mohyuddin A. (2007). Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan. J Heart Valve Dis 16:300–304.
   PubMed Web of Science ®Google Scholar
• Schwentker FF. (1952). The epidemiology of rheumatic fever. In: Thomas L, ed Rheumatic fever. Minneapolis university of Minneapolis Press, 17–27.
   Google Scholar
• Shet A, Kaplan E. (2004). Addressing the burden of group A streptococcal disease in India. Indian J Pediatr 71:41–48.
   PubMedGoogle Scholar
• Siegel AC, Johnson EE, Stollerman GH. (1961). Controlled studies of streptococcal pharyngitis in a pediatric population. Factors related to the attack rate for rheumatic fever. New Eng J Med 265: 559–565.
   Web of Science ®Google Scholar
• Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R. (2003). HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther 5:R340–R346.
   PubMed Web of Science ®Google Scholar
• Visentainer JE, Pereira FC, Dalalio MM, Tsuneto LT, Donadio PR, Moliterno RA. (2000). Association of HLA-DR7 with rheumatic fever in the Brazilian population. J Rheumatol 27:1518–1520.
   PubMed Web of Science ®Google Scholar
• Wani BA. (1997). Study of HLA-A, B, C, DR, DQ profile of patients with established rheumatic heart disease in Kashmir. Indian Heart J 49:152–154.
   PubMedGoogle Scholar